356 related articles for article (PubMed ID: 4556641)
21. Immunosuppressive therapy in rheumatic disease.
Pirofsky B; Bardana EJ
Med Clin North Am; 1977 Mar; 61(2):419-37. PubMed ID: 16187
[No Abstract] [Full Text] [Related]
22. Cytotoxic drugs in treatment of nonmalignant diseases.
Ann Intern Med; 1972 Apr; 76(4):619-42. PubMed ID: 4268240
[No Abstract] [Full Text] [Related]
23. [Immunosuppressive agents].
Gerebtzoff A
Rev Med Liege; 1974 Feb; 29(4):104-7. PubMed ID: 4152567
[No Abstract] [Full Text] [Related]
24. [Immunosuppressive treatments of patients with autoimmune disorders].
Wasastjerna C
Nord Med; 1967 Nov; 78(45):1469-75. PubMed ID: 6070858
[No Abstract] [Full Text] [Related]
25. The drug therapy of ulcerative colitis and of Crohn's disease.
Tumen HJ
Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770
[No Abstract] [Full Text] [Related]
26. [Use of antimetabolites in diseases of auto-aggression].
Romiti N
Hospital (Rio J); 1968 Jan; 73(1):71-8. PubMed ID: 5308511
[No Abstract] [Full Text] [Related]
27. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
Korelitz BI
Gastroenterologist; 1995 Jun; 3(2):141-52. PubMed ID: 7640945
[TBL] [Abstract][Full Text] [Related]
28. [Immunosuppressive treatment in immunopathologic disorders].
Salmon J; Lambert PH
J Belge Rhumatol Med Phys; 1967; 22(4):267-75. PubMed ID: 4390266
[No Abstract] [Full Text] [Related]
29. Posterior subcapsular cataracts. Related to long-term corticosteroid treatment in children.
Bihari M; Grossman BJ
Am J Dis Child; 1968 Dec; 116(6):604-8. PubMed ID: 5697192
[No Abstract] [Full Text] [Related]
30. [Current aspects of immunosuppressive therapy of collagen diseases].
Marmont A; Rossi F; Bordo D
Minerva Med; 1973 Jun; 64(46):2436-50. PubMed ID: 4723570
[No Abstract] [Full Text] [Related]
31. [Collagen diseases].
Katsuta Y; Matsuo H
Nihon Rinsho; 1970 Jul; 28(7):1880-5. PubMed ID: 5466525
[No Abstract] [Full Text] [Related]
32. [Immunosuppressive therapy].
Nelius D; Stieglitz R
Z Arztl Fortbild (Jena); 1971 Jul; 65(14):742-6. PubMed ID: 5123062
[No Abstract] [Full Text] [Related]
33. [Preliminary results with antimetabolite therapy of autoaggressive diseases in dermatology].
Schirren CG
Munch Med Wochenschr; 1965 Dec; 107(50):2553-7. PubMed ID: 4380581
[No Abstract] [Full Text] [Related]
34. [Immunosuppressive treatment of autoantibody anemia and idiopathic thrombocytopenic purpura].
Schumacher K; Gross R
Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):219-23. PubMed ID: 5066427
[No Abstract] [Full Text] [Related]
35. Methotrexate: first-line or second-line immunomodulator?
Fraser AG
Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):225-31. PubMed ID: 12610315
[TBL] [Abstract][Full Text] [Related]
36. Drug therapy: immunosuppressive agents (second of two parts).
Kaplan SR; Calabresi P
N Engl J Med; 1973 Dec; 289(23):1234-6. PubMed ID: 4594161
[No Abstract] [Full Text] [Related]
37. Immunotherapy in inflammatory bowel disease.
Sachar DB; Present DH
Med Clin North Am; 1978 Jan; 62(1):173-83. PubMed ID: 414028
[No Abstract] [Full Text] [Related]
38. [Immunosuppressive agents in hematology].
Sanchez-Fayos J; Outeirino J; Serrano J; Calabuig MT; Paniagua G
Minerva Med; 1970 Jul; 61(55):3082-98. PubMed ID: 4316809
[No Abstract] [Full Text] [Related]
39. [Comparison of various immunosuppressive agents in the treatment of rheumatoid polyarthritis. 41 personal cases].
Vignon G; Bied JC
Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):785-95. PubMed ID: 5152712
[No Abstract] [Full Text] [Related]
40. [Immunosuppressive agents in dermatology].
Schuppli R
Dtsch Med Wochenschr; 1970 Dec; 95(51):2576-7. PubMed ID: 5513651
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
